Coinbase Global Valuation
Is 1QZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 1QZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 1QZ (CHF142.91) is trading above our estimate of fair value (CHF108.59)
Significantly Below Fair Value: 1QZ is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 1QZ?
Other financial metrics that can be useful for relative valuation.
What is 1QZ's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$41.97b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 8.7x |
Enterprise Value/EBITDA | 29.2x |
PEG Ratio | -1.4x |
Price to Earnings Ratio vs Peers
How does 1QZ's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 32.8x | ||
PGHN Partners Group Holding | 34.4x | 14.5% | CHF 33.0b |
UBSG UBS Group | 41.9x | 32.4% | CHF 85.5b |
BAER Julius Bär Gruppe | 28.5x | 21.9% | CHF 10.7b |
VZN VZ Holding | 26.5x | 7.9% | CHF 5.4b |
1QZ Coinbase Global | 28.1x | -20.0% | CHF 42.0b |
Price-To-Earnings vs Peers: 1QZ is good value based on its Price-To-Earnings Ratio (28.1x) compared to the peer average (32.8x).
Price to Earnings Ratio vs Industry
How does 1QZ's PE Ratio compare vs other companies in the European Capital Markets Industry?
Price-To-Earnings vs Industry: 1QZ is expensive based on its Price-To-Earnings Ratio (28.1x) compared to the European Capital Markets industry average (14.4x).
Price to Earnings Ratio vs Fair Ratio
What is 1QZ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 28.1x |
Fair PE Ratio | 16.2x |
Price-To-Earnings vs Fair Ratio: 1QZ is expensive based on its Price-To-Earnings Ratio (28.1x) compared to the estimated Fair Price-To-Earnings Ratio (16.2x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | CHF 142.91 | CHF 210.50 +47.3% | 25.9% | CHF 343.12 | CHF 115.80 | n/a | 23 |
Oct ’25 | CHF 140.27 | CHF 210.34 +50.0% | 25.4% | CHF 340.22 | CHF 114.82 | n/a | 23 |
Sep ’25 | CHF 157.26 | CHF 212.87 +35.4% | 24.5% | CHF 340.60 | CHF 110.69 | n/a | 23 |
Aug ’25 | CHF 203.10 | CHF 223.36 +10.0% | 25.0% | CHF 349.45 | CHF 113.57 | n/a | 24 |
Jul ’25 | CHF 204.42 | CHF 229.47 +12.3% | 26.5% | CHF 403.79 | CHF 116.65 | n/a | 23 |
Jun ’25 | CHF 204.83 | CHF 230.03 +12.3% | 27.4% | CHF 408.70 | CHF 118.07 | n/a | 22 |
May ’25 | CHF 203.24 | CHF 220.55 +8.5% | 33.0% | CHF 413.61 | CHF 101.11 | n/a | 23 |
Apr ’25 | CHF 238.35 | CHF 176.77 -25.8% | 35.6% | CHF 316.58 | CHF 72.36 | n/a | 23 |
Mar ’25 | CHF 177.54 | CHF 145.96 -17.8% | 30.4% | CHF 220.29 | CHF 70.49 | n/a | 23 |
Feb ’25 | CHF 117.46 | CHF 109.66 -6.6% | 34.8% | CHF 172.81 | CHF 51.84 | n/a | 23 |
Jan ’25 | CHF 156.05 | CHF 87.34 -44.0% | 38.6% | CHF 171.11 | CHF 33.37 | n/a | 22 |
Dec ’24 | CHF 114.42 | CHF 75.31 -34.2% | 39.1% | CHF 131.09 | CHF 30.59 | n/a | 23 |
Nov ’24 | CHF 70.69 | CHF 77.40 +9.5% | 40.8% | CHF 136.17 | CHF 24.51 | n/a | 23 |
Oct ’24 | CHF 69.14 | CHF 77.89 +12.7% | 47.4% | CHF 175.69 | CHF 23.72 | CHF 140.27 | 21 |
Sep ’24 | CHF 69.97 | CHF 77.89 +11.3% | 47.4% | CHF 175.69 | CHF 23.72 | CHF 157.26 | 21 |
Aug ’24 | CHF 82.21 | CHF 69.94 -14.9% | 51.7% | CHF 175.05 | CHF 23.63 | CHF 203.10 | 22 |
Jul ’24 | CHF 66.19 | CHF 60.40 -8.7% | 49.8% | CHF 178.25 | CHF 24.06 | CHF 204.42 | 22 |
Jun ’24 | CHF 53.21 | CHF 60.32 +13.4% | 48.9% | CHF 179.02 | CHF 24.17 | CHF 204.83 | 23 |
May ’24 | n/a | CHF 62.73 0% | 49.3% | CHF 179.24 | CHF 26.89 | CHF 203.24 | 22 |
Apr ’24 | CHF 59.63 | CHF 63.29 +6.1% | 51.3% | CHF 182.96 | CHF 27.44 | CHF 238.35 | 21 |
Mar ’24 | n/a | CHF 58.65 0% | 32.5% | CHF 93.15 | CHF 27.95 | CHF 177.54 | 23 |
Feb ’24 | n/a | CHF 52.75 0% | 41.4% | CHF 110.44 | CHF 27.61 | CHF 117.46 | 25 |
Jan ’24 | CHF 32.12 | CHF 66.13 +105.9% | 39.7% | CHF 144.11 | CHF 27.89 | CHF 156.05 | 24 |
Dec ’23 | n/a | CHF 70.28 0% | 37.0% | CHF 147.54 | CHF 39.03 | CHF 114.42 | 24 |
Nov ’23 | CHF 69.91 | CHF 89.60 +28.2% | 41.9% | CHF 217.01 | CHF 41.43 | CHF 70.69 | 24 |
Oct ’23 | n/a | CHF 91.76 0% | 44.1% | CHF 214.96 | CHF 41.04 | CHF 69.14 | 24 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.